RF-SARS-CoV-2 Vaccination and Immunotherapy in Dermatology.
作者信息
Rodríguez-Villa Lario A, Vega-Díez D, Polo-Rodríguez I
机构信息
Servicio de Dermatología, Hospital Universitario Príncipe de Asturias, Universidad de Alcalá de Henares, Meco, Madrid, España.
Servicio de Dermatología, Hospital Universitario Príncipe de Asturias, Universidad de Alcalá de Henares, Meco, Madrid, España.
出版信息
Actas Dermosifiliogr. 2022 Apr;113(4):420-421. doi: 10.1016/j.ad.2021.02.006. Epub 2021 Feb 27.
Abstract
摘要
相似文献
1
RF-SARS-CoV-2 Vaccination and Immunotherapy in Dermatology.
Actas Dermosifiliogr. 2022 Apr;113(4):420-421. doi: 10.1016/j.ad.2021.02.006. Epub 2021 Feb 27.
2
Comment on "An evidence-based guide to SARS-CoV-2 vaccination of patients on immunotherapies in dermatology".
J Am Acad Dermatol. 2021 Aug;85(2):e89-e90. doi: 10.1016/j.jaad.2021.03.038. Epub 2021 Mar 17.
3
Response to comment on "An evidence-based guide to SARS-Cov-2 vaccination of patients on immunotherapies in dermatology.".
J Am Acad Dermatol. 2021 Aug;85(2):e91. doi: 10.1016/j.jaad.2021.04.026. Epub 2021 Apr 17.
4
SARS-CoV-2 (COVID-19) vaccination in dermatology patients on immunomodulatory and biologic agents: Recommendations from the Australasian Medical Dermatology Group.
Australas J Dermatol. 2021 May;62(2):151-156. doi: 10.1111/ajd.13593. Epub 2021 Mar 30.
5
The COVID-19 pandemic and its impact on esthetic dermatology.
J Cosmet Dermatol. 2022 Dec;21(12):6557-6561. doi: 10.1111/jocd.15386. Epub 2022 Sep 26.
6
The Bacterial Mucosal Immunotherapy MV130 Protects Against SARS-CoV-2 Infection and Improves COVID-19 Vaccines Immunogenicity.
Front Immunol. 2021 Nov 18;12:748103. doi: 10.3389/fimmu.2021.748103. eCollection 2021.
7
Vaccination and immunotherapies in neuroimmunological diseases.
Nat Rev Neurol. 2022 May;18(5):289-306. doi: 10.1038/s41582-022-00646-5. Epub 2022 Apr 6.
8
Evidence following guidelines: Another COVID-19 paradox.
J Am Acad Dermatol. 2021 Jan;84(1):37-38. doi: 10.1016/j.jaad.2020.10.070. Epub 2020 Oct 29.
9
Brief Research Report: Anti-SARS-CoV-2 Immunity in Long Lasting Responders to Cancer Immunotherapy Through mRNA-Based COVID-19 Vaccination.
Front Immunol. 2022 Jul 5;13:908108. doi: 10.3389/fimmu.2022.908108. eCollection 2022.
10
Implication of mass COVID-19 vaccination on dermatology practice in 2021.
Dermatol Ther. 2021 Mar;34(2):e14765. doi: 10.1111/dth.14765. Epub 2021 Jan 16.
本文引用的文献
1
An evidence-based guide to SARS-CoV-2 vaccination of patients on immunotherapies in dermatology.
J Am Acad Dermatol. 2021 Jun;84(6):1652-1666. doi: 10.1016/j.jaad.2021.01.047. Epub 2021 Jan 19.
2
Navigating immunosuppression in a pandemic: A guide for the dermatologist from the COVID Task Force of the Medical Dermatology Society and Society of Dermatology Hospitalists.
J Am Acad Dermatol. 2020 Oct;83(4):1150-1159. doi: 10.1016/j.jaad.2020.06.051. Epub 2020 Jun 19.
3
The race for coronavirus vaccines: a graphical guide.
Nature. 2020 Apr;580(7805):576-577. doi: 10.1038/d41586-020-01221-y.
4
2013 IDSA clinical practice guideline for vaccination of the immunocompromised host.
Clin Infect Dis. 2014 Feb;58(3):309-18. doi: 10.1093/cid/cit816.
5
Atypical measles and enhanced respiratory syncytial virus disease (ERD) made simple.
Pediatr Res. 2007 Jul;62(1):111-5. doi: 10.1203/PDR.0b013e3180686ce0.
Zotero 插件